Home/Purple Biotech/Gil Efron

GE

Gil Efron

Chief Financial Officer

Therapeutic Areas

Purple Biotech Pipeline

Drug	Indication	Phase
CM24	Non-Small Cell Lung Cancer	Phase 2
NT219	Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma	Phase 1/2

Leadership Team at Purple Biotech

Chief Executive Officer

Mikael D. Törnqvist

Chief Scientific Officer

View full Purple Biotech profile